User profiles for Kyra H. Grantz
 | Kyra GrantzJohns Hopkins Bloomberg School of Public Health Verified email at jhu.edu Cited by 10131 |
The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application
Background: A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
was identified in China in December 2019. There is limited support for many …
was identified in China in December 2019. There is limited support for many …
Household COVID-19 risk and in-person schooling
In-person schooling has proved contentious and difficult to study throughout the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Data from a massive online …
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Data from a massive online …
The use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology
The ongoing coronavirus disease 2019 (COVID-19) pandemic has heightened discussion
of the use of mobile phone data in outbreak response. Mobile phone data have been …
of the use of mobile phone data in outbreak response. Mobile phone data have been …
Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918
Social factors have been shown to create differential burden of influenza across different
geographic areas. We explored the relationship between potential aggregate-level social …
geographic areas. We explored the relationship between potential aggregate-level social …
A scenario modeling pipeline for COVID-19 emergency planning
Coronavirus disease 2019 (COVID-19) has caused strain on health systems worldwide due
to its high mortality rate and the large portion of cases requiring critical care and mechanical …
to its high mortality rate and the large portion of cases requiring critical care and mechanical …
Effect of specific non-pharmaceutical intervention policies on SARS-CoV-2 transmission in the counties of the United States
Non-pharmaceutical interventions (NPIs) remain the only widely available tool for controlling
the ongoing SARS-CoV-2 pandemic. We estimated weekly values of the effective basic …
the ongoing SARS-CoV-2 pandemic. We estimated weekly values of the effective basic …
Maximizing and evaluating the impact of test-trace-isolate programs: A modeling study
Background Test-trace-isolate programs are an essential part of coronavirus disease 2019 (COVID-19)
control that offer a more targeted approach than many other nonpharmaceutical …
control that offer a more targeted approach than many other nonpharmaceutical …
Development and dissemination of infectious disease dynamic transmission models during the COVID-19 pandemic: what can we learn from other pathogens and …
The current COVID-19 pandemic has resulted in the unprecedented development and
integration of infectious disease dynamic transmission models into policy making and public …
integration of infectious disease dynamic transmission models into policy making and public …
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority …
…, A Juan-Giner, B Orindi, KH Grantz… - The Lancet Infectious …, 2023 - thelancet.com
Background Evidence indicates that fractional doses of yellow fever vaccine are safe and
sufficiently immunogenic for use during yellow fever outbreaks. However, there are no data on …
sufficiently immunogenic for use during yellow fever outbreaks. However, there are no data on …
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial
A Juan-Giner, D Kimathi, KH Grantz, M Hamaluba… - The Lancet, 2021 - thelancet.com
Background Stocks of yellow fever vaccine are insufficient to cover exceptional demands for
outbreak response. Fractional dosing has shown efficacy, but evidence is limited to the …
outbreak response. Fractional dosing has shown efficacy, but evidence is limited to the …
